Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen

NCT02478632 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT02478632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02478632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Completed
Start date
June 12, 2015
Completion date
August 17, 2018
Enrollment
102 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections